[ Price : $8.95]
Federal Register notice: FDA announces an 11/16 public meeting to discuss proposed recommendations for the reauthorization of the ...[ Price : $8.95]
Federal Register notice: Health and Human Services proposes to withdraw a final rule entitled Securing Updated and Necessary Statu...[ Price : $8.95]
FDA announces the availability of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biol...[ Price : $8.95]
Zimmer Biomet recalls its Rosa One 3.1 Brain Application, a robotic platform that helps neurosurgeons with positioning medical ins...[ Price : $8.95]
Federal Register notice: FDA announces a periodic listing of Emergency Use Authorizations for certain medical devices related to t...[ Price : $8.95]
Federal Register notice: FDA posts a list of information collections that have been approved by OMB.[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Enzyvant Therapeutics in response to its approval of a qualified ...[ Price : $8.95]
As HHS suggests increasing access to buprenorphine to treat opioid addiction, manufacturer Purdue Pharma emphasizes its addiction ...